Enrich Therapeutics develops novel single cell isolation technology to enhance global life science research at true single cell level!
Different from all existing flow/microfluidics/droplet-based technologies, our platform is a game-changing innovation and can work on adherent cells and many non-ideal cell samples robustly with high viability.
Enrich team believes that our technology can immediately benefit global investigators to discover all critical human cells especially tumor cells and impact the understanding of many diseases including cancers, thereby obtaining the most precision clinical diagnostic/treatment strategies.
Learn More

Next Steps...

Please fill out the contact form or email us at inquiry@enrichtx.com for any inquiries!